Patients' satisfaction with and views about treatment with disease-modifying drugs in multiple sclerosis

被引：0
|
作者：
Spessotto, Caroline [1 ]
Cavalli, Hanaie [2 ]
Eboni, Audred [3 ]
Machado, Rafael [4 ]
Mousquer, Analara [5 ]
Palazzo, Lara [4 ]
Finkelsztejn, Alessandro [4 ]
Goncalves, Marcos [3 ]
Sato, Henry [2 ]
Siquineli, Fabio [5 ]
Fragoso, Yara [2 ]
机构：
[1] Univ Metropolitana Santos, Sao Paulo, Brazil
[2] Inst Neurol Curitiba, Curitiba, Parana, Brazil
[3] Ctr Hosp Unimed Joinville, Joinville, Brazil
[4] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil
[5] Univ Reg Blumenau, Blumenau, Brazil
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
57
引用
收藏
页码：141 / 141
页数：1
相关论文
共 50 条
  • [21] Fertility, Pregnancy and Childbirth in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs
    Amato, Maria Pia
    Portaccio, Emilio
    CNS DRUGS, 2015, 29 (03) : 207 - 220
  • [22] Audit of patients switching disease-modifying therapies for the treatment of multiple sclerosis
    Embrey, NH
    Woolmore, JA
    Hawkins, CP
    MULTIPLE SCLEROSIS, 2005, 11 : S159 - S159
  • [23] Treatment satisfaction across injectable, infusion, and oral disease-modifying therapies for multiple sclerosis
    Eagle, Tessa
    Stuart, Fiona
    Chua, Alicia S.
    LaRussa, Allison
    Leclaire, Kaitlynne
    Cook, Sandra L.
    Chitnis, Tanuja
    Weiner, Howard L.
    Glanz, Bonnie I.
    Healy, Brian C.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2017, 18 : 196 - 201
  • [24] Improving adherence to injectable disease-modifying drugs in multiple sclerosis
    Bayas, Antonios
    EXPERT OPINION ON DRUG DELIVERY, 2013, 10 (03) : 285 - 287
  • [25] Prevalence of disease-modifying drug treatment gaps in patients with multiple sclerosis
    Joyeux, A.
    Kozma, C.
    Meletiche, D.
    Dickson, M.
    Bennett, R.
    JOURNAL OF NEUROLOGY, 2009, 256 : S163 - S163
  • [26] Disease-Modifying drugs in multiple sclerosis: Current therapeutic schemes
    Jose Rios Martinez, Maria
    Arteaga, Anibal
    Henao, Julieta
    Vagner, Basilio
    Fredy Castro-Alvarez, John
    REVISTA CHILENA DE NEUROPSICOLOGIA, 2020, 15 (01): : 32 - 37
  • [27] Adverse Events Associated With Disease-Modifying Drugs for Multiple Sclerosis
    Ng, Huah Shin
    Zhu, Feng
    Zhao, Yinshan
    Yao, Shenzhen
    Lu, Xinya
    Ekuma, Okechukwu
    Evans, Charity
    Fisk, John D.
    Marrie, Ruth Ann
    Tremlett, Helen
    NEUROLOGY, 2024, 102 (03) : e208006
  • [28] Disease-modifying drugs for multiple sclerosis: current and future aspects
    Freedman, Mark S.
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 : S1 - S10
  • [29] Disease-modifying drugs in multiple sclerosis: a review of expenditure in Ireland
    Bailey, B.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2011, 180 (02) : 337 - 341
  • [30] Disease-modifying drugs in multiple sclerosis: a review of expenditure in Ireland
    B. Bailey
    Irish Journal of Medical Science, 2011, 180 : 337 - 341
12345